Inhibrx Biosciences (INBX) Short Interest Ratio & Short Volume $22.86 +0.74 (+3.35%) Closing price 07/22/2025 04:00 PM EasternExtended Trading$22.87 +0.01 (+0.04%) As of 07/22/2025 05:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Inhibrx Biosciences Short Interest DataInhibrx Biosciences (INBX) has a short interest of 710,700 shares, representing 7.20% of the float (the number of shares available for trading by the public). This marks a -9.18% decrease in short interest from the previous month. The short interest ratio (days to cover) is 6.5, indicating that it would take 6.5 days of the average trading volume of 97,952 shares to cover all short positions.Current Short Interest710,700 sharesPrevious Short Interest782,500 sharesChange Vs. Previous Month-9.18%Dollar Volume Sold Short$10.14 millionShort Interest Ratio6.5 Days to CoverLast Record DateJune 30, 2025Outstanding Shares14,476,000 sharesFloat Size9,870,000 sharesShort Percent of Float7.20%Today's Trading Volume100,854 sharesAverage Trading Volume97,952 sharesToday's Volume Vs. Average103% Short Selling Inhibrx Biosciences? Sign up to receive the latest short interest report for Inhibrx Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartINBX Short Interest Over TimeINBX Days to Cover Over TimeINBX Percentage of Float Shorted Over Time Inhibrx Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/2025710,700 shares $10.14 million -9.2%7.2%6.5 $14.27 6/15/2025782,500 shares $11.40 million +10.7%7.9%7.5 $14.57 5/31/2025707,000 shares $9.59 million -6.5%7.2%6.4 $13.56 5/15/2025756,300 shares $9.09 million +3.6%7.7%6.6 $12.02 4/30/2025729,900 shares $9.00 million -3.6%7.3%6.7 $12.33 4/15/2025757,300 shares $8.93 million -18.9%7.5%7 $11.79 3/31/2025934,200 shares $13.07 million -2.2%9.3%8.6 $13.99 3/15/2025955,400 shares $13.47 million -19.7%9.6%10.5 $14.10 2/28/20251,190,000 shares $15.77 million -7.0%12.0%13.6 $13.25 2/15/20251,280,000 shares $17.14 million +4.9%13.0%15.6 $13.39 Get the Latest News and Ratings for INBX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inhibrx Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/20251,220,000 shares $16.57 million -5.4%12.3%14.1 $13.58 1/15/20251,290,000 shares $17.38 million +3.2%13.0%17 $13.47 12/31/20241,250,000 shares $19.25 million +4.2%12.6%17.4 $15.40 12/15/20241,200,000 shares $17.54 million +10.1%12.1%15.5 $14.62 11/30/20241,090,000 shares $16.63 million +5.8%11.0%12.9 $15.26 11/15/20241,030,000 shares $14.24 million +5.5%10.3%11.2 $13.83 10/31/2024976,700 shares $15.66 million +9.0%9.7%10.9 $16.03 10/15/2024895,700 shares $14.10 million +20.6%8.9%9.2 $15.74 9/30/2024742,500 shares $11.63 million +9.6%7.4%6.9 $15.66 9/15/2024677,700 shares $11.12 million -3.3%6.7%5.2 $16.41 8/31/2024700,700 shares $10.20 million -6.9%6.9%4.5 $14.56 8/15/2024752,900 shares $9.33 million +6.0%7.3%3.7 $12.40 7/31/2024710,400 shares $10.31 million -3.0%7.0%3.1 $14.51 7/15/2024732,600 shares $10.15 million No Change7.2%2.7 $13.86 5/15/20242,050,000 shares $70.46 million -6.4%N/A3.8 $34.37 4/30/20242,190,000 shares $74.55 million -0.5%N/A4.7 $34.04 4/15/20242,200,000 shares $76.43 million +2.3%6.2%3.2 $34.74 3/31/20242,150,000 shares $75.16 million +34.4%6.0%3 $34.96 3/15/20241,600,000 shares $56 million -18.0%4.5%2.1 $35.00 2/29/20241,950,000 shares $71.43 million -7.1%5.5%2.6 $36.63 2/15/20242,100,000 shares $79.78 million -12.5%5.9%3 $37.99 1/31/20242,400,000 shares $92.47 million -41.3%6.7%3.4 $38.53 1/15/20244,090,000 shares $142.74 million +20.3%11.5%6.1 $34.90 12/31/20233,400,000 shares $129.20 million -6.1%9.6%7.4 $38.00 12/15/20233,620,000 shares $101.83 million -30.1%10.2%8.9 $28.13 11/30/20235,180,000 shares $107.59 million -2.1%15.0%12 $20.77 11/15/20235,290,000 shares $107.23 million +5.4%15.3%12 $20.27 10/31/20235,020,000 shares $77.66 million +1.0%15.0%11.2 $15.47 10/15/20234,970,000 shares $87.97 million -7.1%14.9%10.5 $17.70 9/30/20235,350,000 shares $98.17 million +11.2%16.0%11.9 $18.35Is Elon's empire crumbling? (Ad)The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd. Click here to see the Tesla shock that could blindside everyone. 9/15/20234,810,000 shares $100.58 million -5.5%14.4%11.3 $20.91 8/31/20235,090,000 shares $108.93 million -12.8%15.3%12.8 $21.40 8/15/20235,840,000 shares $99.69 million +1.7%17.5%15.7 $17.07 7/31/20235,740,000 shares $115.09 million +0.9%18.0%16.4 $20.05 7/15/20235,690,000 shares $138.32 million -1.4%17.9%17 $24.31 6/30/20235,770,000 shares $149.79 million -4.0%18.2%16 $25.96 6/15/20236,010,000 shares $167.20 million +1.0%20.4%15.8 $27.82 5/31/20235,950,000 shares $140.78 million +3.3%20.2%15.4 $23.66 5/15/20235,760,000 shares $144.86 million +0.4%19.6%13.8 $25.15 4/30/20235,740,000 shares $120.54 million -2.1%19.5%14.1 $21.00 4/15/20235,860,000 shares $106.95 million -0.3%19.9%15.1 $18.25 3/31/20235,880,000 shares $110.96 million -3.0%20.0%14.5 $18.87 3/15/20236,060,000 shares $136.71 million +7.8%20.6%14.4 $22.56 2/28/20235,620,000 shares $135.22 million +8.5%19.1%12.9 $24.06 2/15/20235,180,000 shares $120.90 million -1.7%17.6%12.3 $23.34 1/31/20235,270,000 shares $131.75 million -3.0%19.1%11.7 $25.00 1/15/20235,430,000 shares $128.47 million +26.3%18.1%11.3 $23.66 12/30/20224,300,000 shares $105.95 million +8.6%14.4%8.5 $24.64 12/15/20223,960,000 shares $110.96 million -10.8%13.2%5.4 $28.02 11/30/20224,440,000 shares $133.11 million -1.1%15.7%5.7 $29.98 11/15/20224,490,000 shares $146.82 million -2.8%15.9%5.8 $32.70 10/31/20224,620,000 shares $148.67 million +16.7%18.0%6.2 $32.18 10/15/20223,960,000 shares $118.21 million -4.1%15.5%5.5 $29.85 9/30/20224,130,000 shares $74.13 million +25.5%16.2%5.9 $17.95 9/15/20223,290,000 shares $48.66 million +0.6%12.9%6.9 $14.79 8/31/20223,270,000 shares $58.01 million +0.3%12.8%7.2 $17.74 8/15/20223,260,000 shares $80.46 million -13.3%12.8%7.5 $24.68 7/31/20223,760,000 shares $65.20 million +5.3%14.4%7.7 $17.34 7/15/20223,570,000 shares $61.69 million +15.2%13.7%7.2 $17.28 6/30/20223,100,000 shares $35.19 million -9.6%11.9%6.5 $11.35 6/15/20223,430,000 shares $30.73 million +4.6%13.2%8 $8.96 5/31/20223,280,000 shares $42.87 million +35.0%12.6%8.8 $13.07 5/15/20222,430,000 shares $41.16 million +12.0%9.4%7.2 $16.94 4/30/20222,170,000 shares $34.39 million +7.4%8.3%7.6 $15.85 4/15/20222,020,000 shares $37.01 million -10.2%7.7%7.1 $18.32 3/31/20222,250,000 shares $50.13 million +8.7%8.6%8 $22.28 3/15/20222,070,000 shares $41.77 million +0.5%7.9%7.4 $20.18 2/28/20222,060,000 shares $44.29 million -3.3%7.9%7 $21.50 2/15/20222,130,000 shares $51.87 million +13.3%8.2%7.5 $24.35 1/31/20221,880,000 shares $49.93 million +67.9%8.3%7.3 $26.56 1/15/20221,120,000 shares $35.26 million +4.7%N/A0 $31.48 12/31/20211,070,000 shares $46.73 million +56.0%4.7%4.5 $43.67 12/15/2021685,900 shares $27.83 million +5.6%3.0%2.9 $40.58 11/30/2021649,700 shares $26.27 million +1.3%2.9%3.3 $40.43 11/15/2021641,400 shares $28.54 million -25.2%2.8%3.4 $44.49 10/29/2021857,700 shares $34.47 million +4.1%3.8%4.6 $40.19 10/15/2021823,900 shares $32.72 million -3.8%3.7%4.7 $39.71 9/30/2021856,500 shares $28.53 million +17.6%3.8%6.5 $33.31 9/15/2021728,400 shares $26.37 million -10.0%3.2%4 $36.20 8/31/2021808,900 shares $23.07 million -20.7%3.6%4 $28.52Is Elon's empire crumbling? (Ad)The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd. Click here to see the Tesla shock that could blindside everyone. 8/13/20211,020,000 shares $28.18 million -8.1%4.5%4.5 $27.63 7/30/20211,110,000 shares $31.59 million +0.9%4.9%5.1 $28.46 7/15/20211,100,000 shares $27.70 million -1.8%4.9%5.3 $25.18 6/30/20211,120,000 shares $30.82 million +35.0%5.0%5.3 $27.52 6/15/2021829,900 shares $21.54 million +6.5%3.7%5.2 $25.95 5/28/2021779,100 shares $16.49 million +1.3%3.5%6.4 $21.16 5/14/2021768,900 shares $12.93 million -8.2%3.4%6.6 $16.82 4/30/2021837,100 shares $16.43 million +5.1%3.7%5.3 $19.63 4/15/2021796,400 shares $16.58 million +52.1%3.6%5.3 $20.82 3/31/2021523,600 shares $8.86 million -21.7%2.3%3.6 $16.93 3/15/2021668,400 shares $15.71 million +19.6%3.0%3.9 $23.51 2/26/2021558,800 shares $14.98 million -8.2%2.5%3.3 $26.80 2/12/2021608,900 shares $22.53 million +4.3%2.7%3.9 $37.00 1/29/2021583,800 shares $19.08 million -16.8%2.6%5.7 $32.68 1/15/2021701,600 shares $25.26 million No Change3.2%6.6 $36.00 INBX Short Interest - Frequently Asked Questions What is Inhibrx Biosciences' current short interest? Short interest is the volume of Inhibrx Biosciences shares that have been sold short but have not yet been closed out or covered. As of June 30th, investors have sold 710,700 shares of INBX short. 7.20% of Inhibrx Biosciences' shares are currently sold short. Learn More on Inhibrx Biosciences' current short interest. What is a good short interest ratio for Inhibrx Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INBX shares currently have a short interest ratio of 6.0. Learn More on Inhibrx Biosciences's short interest ratio. What is a good short interest percentage for Inhibrx Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.20% of Inhibrx Biosciences' floating shares are currently sold short. Is Inhibrx Biosciences' short interest increasing or decreasing? Inhibrx Biosciences saw a decrease in short interest in June. As of June 30th, there was short interest totaling 710,700 shares, a decrease of 9.2% from the previous total of 782,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Inhibrx Biosciences' float size? Inhibrx Biosciences currently has issued a total of 14,480,000 shares. Some of Inhibrx Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Inhibrx Biosciences currently has a public float of 9,870,000 shares. How does Inhibrx Biosciences' short interest compare to its competitors? 7.20% of Inhibrx Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Inhibrx Biosciences: Harrow, Inc. (13.27%), Phibro Animal Health Corporation (4.68%), AbCellera Biologics Inc. (13.58%), Cogent Biosciences, Inc. (11.75%), Pharvaris N.V. (4.50%), Intellia Therapeutics, Inc. (30.02%), CureVac N.V. (0.93%), Aurinia Pharmaceuticals Inc (8.39%), WAVE Life Sciences Ltd. (73.25%), Enliven Therapeutics, Inc. (15.81%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), Strategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Inhibrx Biosciences stock? Short selling INBX is an investing strategy that aims to generate trading profit from Inhibrx Biosciences as its price is falling. INBX shares are trading up $0.84 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Inhibrx Biosciences? A short squeeze for Inhibrx Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INBX, which in turn drives the price of the stock up even further. How often is Inhibrx Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INBX, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies HROW Short Squeeze PAHC Short Squeeze ABCL Short Squeeze COGT Short Squeeze PHVS Short Squeeze NTLA Short Squeeze CVAC Short Squeeze AUPH Short Squeeze WVE Short Squeeze ELVN Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INBX) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibrx Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inhibrx Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INBX Stock Alerts